Print 
Share 
Text 
To reset, hold the Ctrl key, then press 0.
Postdoctoral fellow Dr. Zhaohong (Tina) Qin’s passion for mental health research led her to discover that the brain’s pathways for anxiety and obesity are linked, opening up possibilities for new treatments.
Some days Dr. Zhaohong (Tina) Qin has to remind herself to leave the lab and go home. She becomes so absorbed in watching neurons fire that she loses track of time.
”You apply the drug and you can see the change right away,” said the postdoctoral fellow at The Ottawa Hospital and the University of Ottawa. “I love it so much – nothing else makes me feel so alive.”
Dr. Qin was no stranger to research when she immigrated to Canada 11 years ago. In China she worked in the pharmaceutical industry, discovering new drugs and finding different ways to diagnose diseases.
“Research in mental health has the first place in my mind and heart,” Dr. Qin explained. “One of my best friends died by suicide. I want to use my skills to help treat these challenging conditions that affect so many people.”
During her PhD in Dr. Hsiao-Huei Chen’s lab, Dr. Qin made a surprising discovery. She found that a drug called trodusquemine, which controls weight gain, could also relieve anxiety in mice. This meant that somehow the brain pathways for anxiety and obesity were linked.
Right away, Dr. Qin wanted to find out why. After many additional tests and experiments, she found the reason: an enzyme called PTP1B. When it is overactive, this enzyme helps cause both anxiety and obesity. The drug trodusquemine lets the brain fix itself by bringing the levels of PTP1B back to normal.
“It’s our hope that this exciting finding can move to the clinic, and that this drug can be used to fight two diseases at once,” said Dr. Qin.
But Dr. Qin isn’t stopping there. She’s currently investigating whether this drug can also treat other mental health conditions that involve overactive PTB1B, such as Alzheimer’s disease and schizophrenia.
Praised by her colleagues for her strength, drive, independence and determination, Dr. Qin has published 12 research articles, many in high-impact journals such as Neuron and Journal of Neuroscience. Despite her successes, she will be the first to admit that a career in neuroscience can also be challenging.
“It’s easy to get frustrated when experiments fail, but I cannot give up,” said Dr. Qin. “If I want my research to help people, it can’t just stay in the lab.”
Dr. Qin has been selected as the hospital’s top research trainee of the year. She will be presented with the Worton Researcher in Training Award at The Ottawa Hospital Gala on Nov. 5.
Comment on this post
Support patient care and research at
The Ottawa Hospital
Dear Dr. Qin, Congratulations on winning this award as the Ottawa Hospital’s top research trainee. Your story is a wonderful example of hard work mixed with serendipity in research – a combination that fueled my own career. You are exactly the type of person we had in mind when the award was created. I am sorry that I will not be there to present it. Ron Worton
Hi Ronald, thank you for submitting a comment. I will be sure to share your kind words to Dr. Qin. Take care.
Congratulations Dr. Zhaohong (Tina) Qin,
Having family members, friends and patients challenged with obesity, anxiety, schizophrenia, and other conditions mentioned,it is a delight to read of your enthusiasm and success in this field. Bravo! …and Thank You!
When would human clinical trials start
Thank you for your question D Crawford. We are still investigating these exciting findings in the lab. It will be many years before we can start trials in humans.
That is so awesome, and it explains so much! Thank you for your dedication, and I hope that your hard work pays off and helps many people in the future! No wonder they say exercise helps your anxiety!
Thank you for submitting a comment. I will share your enthusiasm for this study with Dr. Qin. All the best!